Kenvue Inc.
Health
Performance
8.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

Score & Rating History

Every shift in sentiment, performance and analyst outlook – transparently logged.

17.10.2025
Red alert. Risk levels out of control.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

Price moves, patterns & momentum

From daily swings to long-term trends – track it all right here.

What this company is all about

Get the full picture: what they build, where they operate, and how they make money.

Kenvue Inc. Profile

Sector: Consumer Defensive

Industry: Household & Personal Products

Employees (FY): 22000

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

shop
Company facts
Thibaut Mongon
CEO
22000
Employees worldwide
shop
Performance
-35.07%
Last 12 months
shop
Growth
$15,46B
Revenue year
$1,03B
Net income
shop
Valuation
$29,34B
Market Cap
39.38
Price/Earnings Ratio

Everything that moves Kenvue Inc.

From earnings beats to CEO slip-ups – here’s where you catch every move that could impact the stock.

No News Available
There’s nothing new to display at the moment. Check back later for the latest updates and stories!

Technical signals decoded

What the indicators are saying – across all timeframes.